Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Serina Therapeutics (SER) just unveiled an update.
Serina Therapeutics, Inc. announced that their Chief Development Officer, Dr. Randall Moreadith, will attend the 4th Annual mRNA-Based Therapeutics Summit in Boston from July 29 to July 31, 2024. At this event, Dr. Moreadith will present using materials that are referenced in the company’s latest report. While this information is shared with the public, it is not filed under formal regulatory frameworks and is not to be considered a decisive factor in investment decisions regarding the company’s securities.
For detailed information about SER stock, go to TipRanks’ Stock Analysis page.
